Brexit: Panicky Government to splash cash in bid to boost stricken economy

Ministers trumpet Merck investment, but what about the ones being cancelled thanks to the Brexit Stalinists? 

James Moore
Chief Business Commentator
Monday 27 November 2017 12:21
Comments
Drugs: ministers want pharmaceuticals to play a key role in the country’s future economy
Drugs: ministers want pharmaceuticals to play a key role in the country’s future economy

“A huge vote of confidence,” is how the Government, with no false modesty, described an investment of up to £1bn by MSD (Merck in the US) in a UK research centre, the launch of which was timed to coincide with its post-Brexit economy plan.

Ministers are desperately keen to trumpet this sort of thing. Those not part of the Gove / Johnson politbureau are rightly nervous about what’s going to happen when the hammer comes down.

Stumbledore Liam Fox can witter on about waving his wand and signing trade deals, but if the weekend rumblings from Australia are anything to go by – it treated his ideas with the sort of disdain with which its cricketeers treated England’s bowlers – then they won’t be able to rely on him for help.

The problem with announcements like the one from MSD/Merck, and those we’ve seen from the likes of Facebook and Google, is that for every one of them there’s at least one, or two or three, big investments being cancelled.

A rare public example of that came over the weekend with The Daily Telegraph reporting on the cancellation of plans for a research centre from another company operating in the healthcare sector, Johnson & Johnson. The reason? Economic uncertainty, created by that newspaper’s beloved Brexit.

There are many more like that, however, that we will never hear about. Governments and businesses are much less likely to report on what they’re not doing than what they are.

Lots of businesses are sitting on their hands right now. Still more are putting contingency plans in place to shift jobs and investment away from this country.

Business investment crawled up by just 0.2 per cent in the last quarter, the weakest since the end of last year, which tells you all you need to know. Businesses don’t want to spend money in the absence of any real idea of what’s going to confront them in just over a year’s time.

The Government’s plan is supposed to address that. Brexit may be the bastard child of nostalgic Thatcherites, but its result has been the slaughter of one of their sacred cows: the view that the state should not intervene in industry and instead leave the market to its own devices.

To draw in companies like Merck, and multinational operators in other industries that ministers think the UK is good at – AI, for example, as well as healthcare / pharmaceuticals – it plans to shower taxpayers’ cash upon them.

Critics of this approach, and there are plenty, will lament this as an attempt to pick winners (no, no, we’re boosting excellence!) while highlighting the UK’s dreadful past record on that front.

But their laissez faire approach has left us with deep economic problems, such as an overly dominant financial services sector that powers London and the South-east while much of the rest of the country shivers.

A more balanced economy, which might have resulted had previous governments attempted to address this problem earlier, would probably have led to a more balanced country, one more at ease with itself and less prone to the lies of populist, self interested Brexiteers.

Unfortunately, this Government has woken up to the problem and performed a volte face in the midst of a crisis, with much of the City preparing to flee, taking a big chunk of the £70bn-plus in annual tax revenues it contributes with it.

Policymaking in the midst of a crisis rarely good policymaking. As for where the funding for its interventionist plans is going to come from long term? Answers on a postcard, please.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in